Hydra Biosciences - Pre-Clinical Pain Program - Ownership and Business Overview

Life ScienceCompany

Hydra Biosciences - Pre-Clinical Pain Program Ownership

Who owns Hydra Biosciences - Pre-Clinical Pain Program?

Hydra Biosciences - Pre-Clinical Pain Program is owned by Eli Lilly. It was acquired on December 14, 2018.

Hydra Biosciences - Pre-Clinical Pain Program Business Overview

Where is Hydra Biosciences - Pre-Clinical Pain Program headquartered?

Hydra Biosciences - Pre-Clinical Pain Program is headquartered in Cambridge, Massachusetts.

What sector is Hydra Biosciences - Pre-Clinical Pain Program in?

Hydra Biosciences - Pre-Clinical Pain Program is a life science company.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 248 acquisitions of life science companies in 2018, including 45 acquisitions by private equity firms, and 203 by strategics.

Hydra Biosciences, Inc. - Pre-Clinical Pain Program

Cambridge, Massachusetts 02138
United States,

Hydra Biosciences, Inc. - Pre-Clinical Pain Program of TRPA1 antagonists, part of the Transient Receptor Potential (TRP) family of ion channels, that is currently being studied for the potential treatment of chronic pain syndromes.


Company Summary

SECTOR

Life Science

 Subscribe to unlock this and 209,497
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Hydra Biosciences - Pre-Clinical Pain Program

Massachusetts Companies , Life Science Companies , United States Companies , Massachusetts Life Science Companies , Massachusetts Life Science with Acquisitions , Massachusetts Life Science with Divestitures

Related Lists for Massachusetts Companies

Largest Massachusetts Companies , Acquisitive Massachusetts Companies , Recently Acquired Massachusetts Companies , Recently Sold Massachusetts Companies , Private Massachusetts Companies , Public Massachusetts Companies , Acquired Massachusetts Companies , PE Backed Massachusetts Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal